3-[4-(lH-imidazol-l-ylmethyl)phenyl]-5-(2-methylpropyl) thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt

3-[4-(lH-imidazol-l-ylmethyl)phenyl]-5-(2-methylpropyl) thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt
Trade Name
Orphan Indication Idiopathic pulmonary fibrosis
USA Market Approval USA
USA Designation Date 2017-01-25 00:00:00
Sponsor Vicore Pharma;c/o AstraZeneca, Pepparedsleden 1;M´┐Żlndal